Contribution of ayurveda for management of ADHD (attention deficit hyperactivity disorder): A case report

Punam Sawarkar; Shilpa Yerme; Manju Mohan; Gaurav Sawarkar

doi:10.53730/ijhs.v6nS2.5053

Authors

Punam Sawarkar
drsuple.punam@gmail.com
Associate Professor, Department of Panchakarma, Mahatma Gandhi Ayurved College Hospital and Research Centre, Salod, Datta Meghe Institute of Medical Sciences (DMIMS), Wardha, Maharashtra, India
Shilpa Yerme Professor, Department of Kriyasharir, SGR Ayurved College, Solapur, Maharashtra India
Manju Mohan Assistant Professor, Department of Panchakarma, Om Ayurvedic Medical College & Hospital, Betul, Madhya Pradesh, India
Gaurav Sawarkar Associate Professor, Department of Rachana Sharir, Mahatma Gandhi Ayurved College Hospital and Research Centre, Salod(H), Datta Meghe Institute of Medical Sciences (DMIMS), Wardha, Maharashtra, India

Keywords:

ADHD, Kashaya Basti, Matrabasti, Nasya, Unmada, Utsadana

Abstract

Attention deficit hyperactive disorder (ADHD) is one of the commonest neurobehavioral disorders of childhood, affecting social, learning, and behavioral abilities with a prevalence rate in India of 1.3 per 1000. In Ayurveda, specific mental clinical conditions associated with psychiatric and behavioral disturbances are elaborated under the term “Unmada.” The Unmada is such a condition compromising particular emotional, behavioral, psychological, and physical features. Attention Deficit Hyperactivity Disorder (ADHD) is a neurobehavioral disorder of childhood that mostly occurs in school-going children. Hyperactivity and inattention are the common clinical features of this disease. Both these symptoms are already narrated in ‘Unmada’ mentioned in Ayurveda. Its prognosis is Sadhya (Curable) by treating it with internal medications and various therapeutic procedures. Ayurveda suggests the treatment protocols, Snehana (Oleation), Swedana (Sudation), Shodhana (Purificatory) procedures like Vamana (Emesis), Virechana (Purgation), Basti (Medicated enema), Nasya, Dhumapana (Medicated smoke), Anjana (Collyrium application), Abhyanga (Massage), Lepa (External application), Parisheka (Oil bath) also Shaman Chikitsa (Internal medication). This case study aimed to assess the efficacy of Ayurvedic management for the management of ADHD. Nine years old male child presented with their parents at Ayurvedic hospital with complaints of hyperactivity, unable to speak properly, lack of concentration, recurrent anger.

Downloads

Download data is not yet available.

References

Vinod K Paul, Arvind Bagga. Ghai essential in Pediatrics. 9 ed. New Delhi; CBS Publishers and Distributors Pvt Ltd. 2019, p.51

Kleigmn, Behirman. Nelson textbook of Pediatrics 18 ed. Philadelphia: Saunders publishers. 2008; p.146

Kleigman, Stanton, Stegeme. Nelson textbook of Pediatrics. Volume 1, Reprinted. India: Elsevier, Relix India Private Limited. 2017. Chapter no 33, Learning disorder, p. 200

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (Fifth ed.). Arlington, VA: American Psychiatric Publishing. 2013, p. 5–25

Ibidem Nelson textbook of Pediatrics (3), Chapter no 33, Learning disorder, p. 203

Agnivesha, Charaka, Dridhabala, Charaka Samhita, Nidaan Sthana, Unmadanidaan Adhyaya, edited by Vaidya Vidhyadhar Shukla, Ravidatta Tripathi. 2nded. Varanasi: Chaukhamba Sanskriti Pratishthan, 2005; p.532

Vagbhata, Ashtang Hriday, Uttara Sthana, Unmada Pratisheda Adhayaya, edited by Bramhanad Tripathi, Reprinted. Delhi: Chaukhambha Sanskrita Prathishthan. 2014, p. 921

Agnivesha, Charaka, Dridhabala, Charaka Samhita, Nidaan Sthana, Unmadachikitsit Vyakhynam, edited by Banvarilal Gaud, 1st ed. New Delhi: Rashtriya Ayurveda Vidyapeeth. 2014; p.548

Ibidem Charaka Samhita (8), Chikitsa Sthana, Unmadachikitsit Vyakhynam, p.550.

KC R, Dash PK. A Conceptual Review of Manas in Relation to Attention-Deficit Hyperactivity Disorder (ADHD) In Children. International Journal of Ayurvedic Medicine. 2017;8(3):105-9.

Kar PK. Udvartana–Samvahana Vis-A-Vis Effleurage. International Ayurvedic Medical Journal. 2015;3(6); p.1811.

Vaidya Jadavji Trikamji Acharya, Charak Samhita of Agnivesa with Ayurved-Deepika Commentary of Sri Chakrapanidatta, Sutra Sthana, 5/83, Chaukhamba Publication, Delhi, Reprint Edition 2017, p. 78.

Ironson G, Field T, Scafidi F, Hashimoto M, Kumar M, Kumar A, Price A, Goncalves A, Burman I, Tetenman CY, Patarca R. Massage therapy is associated with enhancement of the immune system's cytotoxic capacity. International Journal of neuroscience. 1996 Jan 1;84(1-4):205-17.

Treating ADHD with massage therapy. Pacific College of Oriental Medicine. Blog:22 Dec2014. [Cited on 10 August 2021]. Available From: https://www.pacificcollege.edu/news/blog/2014/12/22/treating-adhd-with-massage-therapy.

Sawarkar G, Sawarkar P. Management of obsessive-compulsive disorder (OSD) through Ayurveda. J. Ind. Sys. Med. 2018 Jul 1;6(3):157-65.

Tripathi B, editor. Nasyavidhi adhyaya. Verse 1. In: Vagbhata, Ashatang Hrudaya, Sutrasthana. Delhi, India: Chaukhamaba Sanskrit Pratishthan; 2015. p. 243.

Srikanth KY, Krishnamurthy V, Srinivasulu M. Pharmacodynamics of Nasya karma. International Journal of Ayurveda & Pharmacy. 2011 Jan;2(1):24-6.

Vaidya Jadavji Trikamji Acharya, Charak Samhita of Agnivesa with Ayurved-Deepika Commentary of Sri Chakrapanidatta, Siddhi Sthana, 1/38-39, Chaukhamba Publication, Delhi, Reprint Edition 2017, p.683.

Vaidya Jadavji Trikamji Acharya, Sushrut Samhita of Sushrut with Nibandhasamgraha Commentary of Sri Dalhanacharya, Chikitsa Sthana, 35/6, Chaukhamba Samskrit Samsthana, Varanasi, Reprint Edition 2017, p.525.

Vaidya Jadavji Trikamji Acharya, Sushrut Samhita of Sushrut with Nibandhasamgraha Commentary of Sri Dalhanacharya, Shareera Sthana, 1/20, Chaukhamba Samskrit Samsthana, Varanasi, Reprint Edition 2017, p.489.

Tubaki BR, Chandrashekar CR, Sudhakar D, Prabha TN, Lavekar GS, Kutty BM. Clinical efficacy of Manasamitra Vataka (an Ayurveda medication) on generalized anxiety disorder with comorbid generalized social phobia: a randomized controlled study. The Journal of Alternative and Complementary Medicine. 2012 Jun 1;18(6):612-21.

B.N. Dhawan. Experimental and Clinical Evaluation of Nootropic Activity of Bacopa monniera Linn. (Brahmi). Ann Natl Acad Med Sci 2014; 50:20-33.

Mahato SB, Garai S, Chakravarty AK. Bacopa saponins E and F: Two jujubogenin bisdesmosides from Bacopa monniera. Phytochemistry 2000; 53:711-4.

Govinda Das, Bhaishajya Ratnavali. with ‘Vidyotini’ Hindi Vyakhya by Ambikadatta Shastri, edited by Rajeshvaradatta Shastri, 19th edition, Chaukhamba Sanskrit Sansthan, Varanasi, Unmada chikitsa, 2008; 24(26-29):513.

Abbafati, Cristiana, Kaja M. Abbas, Mohammad Abbasi, Mitra Abbasifard, Mohsen Abbasi-Kangevari, Hedayat Abbastabar, Foad Abd-Allah, et al. “Global Burden of 369 Diseases and Injuries in 204 Countries and Territories, 1990-2019: A Systematic Analysis for the Global Burden of Disease Study 2019.” LANCET 396, no. 10258 (October 17, 2020): 1204–22.

Ghogare, Ajinkya Sureshrao, Sally John, Pradeep Shriram Patil, and Ganpatlal Kodarbhai Vankar. “Study of Iron Profile and Effect of Oral Iron Supplementation in Patients of Attention Deficit Hyperactivity Disorder in Rural Tertiary Health Care Centre from Central India: A Case Series.” JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH 14, no. 10 (October 2020). https://doi.org/10.7860/JCDR/2020/43748.14144.

James, Spencer L., Chris D. Castle, Zachary Dingels V, Jack T. Fox, Erin B. Hamilton, Zichen Liu, Nicholas L. S. Roberts, et al. “Global Injury Morbidity and Mortality from 1990 to 2017: Results from the Global Burden of Disease Study 2017.” INJURY PREVENTION 26, no. SUPP_1, 1 (October 2020): 96–114. https://doi.org/10.1136/injuryprev-2019-043494.

Steg PG, Szarek M, Bhatt DL, Bittner VA, Bregeault MF, Dalby AJ, Diaz R, Edelberg JM, Goodman SG, Hanotin C, Harrington RA. Effect of alirocumab on mortality after acute coronary syndromes: an analysis of the ODYSSEY OUTCOMES randomized clinical trial. Circulation. 2019 Jul 9;140(2):103-12.

Khatib N, Gaidhane S, Gaidhane AM, Khatib M, Simkhada P, Gode D, Zahiruddin QS. Ghrelin: ghrelin as a regulatory Peptide in growth hormone secretion. Journal of clinical and diagnostic research: JCDR. 2014 Aug;8(8):MC13.

Bourne R, Steinmetz JD, Flaxman S, Briant PS, Taylor HR, Resnikoff S, Casson RJ, Abdoli A, Abu-Gharbieh E, Afshin A, Ahmadieh H. Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study. The Lancet Global Health. 2021 Feb 1;9(2):e130-43.